Drugs Made In America Acquisition II Corp. Unit
Not enough financial coverage to compute a composite score for DMIIU. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companydmaacorp.com
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U. S.
- CEO
- Roger Bendelac
- IPO
- 2025
- Employees
- 2
- HQ
- Fort Lauderdale, FL, US
Price Chart
Performance & Tape
- 52W High
- $10.80
- 52W Low
- $9.94
- 50D MA
- $10.06
- 200D MA
- $10.04
- Beta
- 0.05
- Avg Volume
- 3.33K
Get TickerSpark's AI analysis on DMIIU
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DMIIU Coverage
We haven't published any research on DMIIU yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DMIIU Report →